Lu, Z., Du, W., Jiao, X., Wang, Y., Zhang, Z., Shen, L. (2025). Reply to: “
                    <i>NOTCH1</i>
                    : A Potential New Biomarker in the Era of Immunotherapy?” and “Caution in Interpreting
                    <i>NOTCH1</i>
                    Mutation as a Predictive Biomarker of Tislelizumab Response in Esophageal Squamous Cell Carcinoma”. Journal of Clinical Oncology. https://doi.org/10.1200/jco-25-01535